Could cause temporary or reversible harm; serious harm is unlikely.
Failed Dissolution Specifications
| Brand name | PENICILLAMINE |
| Generic name | PENICILLAMINE |
| Active ingredient(s) | PENICILLAMINE |
| Distributed by / for | Lupin Pharmaceuticals, Inc. Baltimore, MD 21202 |
| NDC | 70748-153-01 |
| Full product label | Penicillamine Tablets USP 250 mg, 100-count bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, MD 21202 Manufactured by: Lupin Limited, Nagpur-441 108, India, NDC# 70748-153-01 |
| Recalling firm | Lupin Pharmaceuticals Inc. |
| Distribution | Product was distributed to 3 wholesale/distributor accounts. |
| Quantity | N/A |
| Recall initiated | 2023-11-22 |
| Report date | 2023-12-20 |
| Recall completed | 2024-07-08 |
| Recall number | D-0148-2024 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Baltimore MD United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗